ECSP077238A - Composiciones para entrega de drogas altamente solubles en agua - Google Patents
Composiciones para entrega de drogas altamente solubles en aguaInfo
- Publication number
- ECSP077238A ECSP077238A EC2007007238A ECSP077238A ECSP077238A EC SP077238 A ECSP077238 A EC SP077238A EC 2007007238 A EC2007007238 A EC 2007007238A EC SP077238 A ECSP077238 A EC SP077238A EC SP077238 A ECSP077238 A EC SP077238A
- Authority
- EC
- Ecuador
- Prior art keywords
- compositions
- delivery
- water
- soluble drugs
- highly soluble
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención suministra composiciones para la entrega de drogas altamente solubles en agua y métodos para usar tales composiciones.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/889,226 US7871632B2 (en) | 2004-07-12 | 2004-07-12 | Compositions for delivering highly water soluble drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP077238A true ECSP077238A (es) | 2007-04-26 |
Family
ID=35541622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2007007238A ECSP077238A (es) | 2004-07-12 | 2007-02-12 | Composiciones para entrega de drogas altamente solubles en agua |
Country Status (19)
Country | Link |
---|---|
US (4) | US7871632B2 (es) |
EP (1) | EP1773294A4 (es) |
JP (1) | JP4643641B2 (es) |
KR (1) | KR20070032816A (es) |
CN (1) | CN1859898B (es) |
AU (1) | AU2005271873A1 (es) |
BR (1) | BRPI0513178A (es) |
CA (1) | CA2578574C (es) |
EA (1) | EA012522B1 (es) |
EC (1) | ECSP077238A (es) |
HK (1) | HK1100062A1 (es) |
IL (1) | IL180350A0 (es) |
MA (1) | MA29662B1 (es) |
MX (1) | MX2007000416A (es) |
NO (1) | NO20070785L (es) |
RS (1) | RS20070029A (es) |
TW (1) | TW200607525A (es) |
WO (1) | WO2006017246A2 (es) |
ZA (1) | ZA200701167B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1778217A4 (en) * | 2004-07-28 | 2008-10-08 | Sd Pharmaceuticals Inc | STABLE INJECTABLE COMPOSITION OF ALPHA-TOCOPHERYLSUCCINATE; ANALOGUE AND SALTS FROM IT " |
US8557861B2 (en) * | 2004-09-28 | 2013-10-15 | Mast Therapeutics, Inc. | Low oil emulsion compositions for delivering taxoids and other insoluble drugs |
TWI376239B (en) * | 2006-02-01 | 2012-11-11 | Andrew Xian Chen | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
CN101011355B (zh) * | 2006-02-01 | 2013-01-02 | 陈献 | 经维生素e琥珀酸酯稳定的医药组合物、其制备及用途 |
CN101472562A (zh) * | 2006-05-12 | 2009-07-01 | 陈献 | 用于静脉刺激性药物的药物组合物 |
WO2009078754A1 (en) | 2007-12-19 | 2009-06-25 | Ardenia Investments, Ltd. | Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
WO2009078756A1 (en) | 2007-12-19 | 2009-06-25 | Ardenia Investments, Ltd. | Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
US8906855B2 (en) * | 2007-12-22 | 2014-12-09 | Vivacelle Bio, Inc. | Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
US8063020B2 (en) * | 2007-12-22 | 2011-11-22 | Simpkins Cuthbert O | Resuscitation fluid |
US8618056B2 (en) * | 2007-12-22 | 2013-12-31 | Cuthbert O. Simpkins | Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries |
CA2716546A1 (en) * | 2008-02-25 | 2009-09-03 | Novavax, Inc. | Sugar glassified virus like particles (vlps) |
US20090286832A1 (en) * | 2008-05-15 | 2009-11-19 | Kiichiro Nabeta | Narcotic emulsion formulations for treatment of surgical pain |
EP2400838B1 (en) * | 2009-02-26 | 2016-05-11 | Teikoku Pharma USA, Inc. | Narcotic emulsion formulations for treatment of cancer pain |
CN101879138A (zh) | 2009-05-06 | 2010-11-10 | 上海恒瑞医药有限公司 | 长春花生物碱纳米乳剂注射液及其制备方法 |
SG10201407538WA (en) * | 2009-08-14 | 2015-01-29 | Opko Health Inc | Intravenous formulations of neurokinin-1 antagonists |
CA2814577C (en) * | 2010-10-22 | 2019-06-04 | Dr. Reddy`S Laboratories, Inc. | Use of storage stable viscous phospholipid depot to treat wounds |
WO2012135856A2 (en) * | 2011-04-01 | 2012-10-04 | Spectrum Pharmaceuticals, Inc. | Very low dose vinorelbine for treatment of cancer |
CN102743337B (zh) * | 2011-04-20 | 2014-04-16 | 国家纳米科学中心 | 一种纳米粒子药物组合物及其制备方法 |
EP2717853A4 (en) * | 2011-06-09 | 2014-11-05 | Amylin Pharmaceuticals Llc | COMPOSITIONS OF GELS |
WO2013059922A1 (en) | 2011-10-25 | 2013-05-02 | The University Of British Columbia | Limit size lipid nanoparticles and related methods |
CN104427976B (zh) | 2012-05-10 | 2018-04-24 | 佩因拉佛姆有限公司 | 疏水的活性成分的储库制剂及其制备方法 |
CA2906732C (en) | 2013-03-15 | 2023-08-08 | The University Of British Columbia | Lipid nanoparticles for transfection and related methods |
US20140275261A1 (en) | 2013-03-15 | 2014-09-18 | Dr. Reddy's Laboratories, Inc. | Diclofenac parenteral compositions |
US20160290093A1 (en) * | 2015-04-02 | 2016-10-06 | Baker Hughes Incorporated | Disintegrating Compression Set Plug with Short Mandrel |
CN108348581B (zh) | 2015-09-04 | 2022-07-01 | 斯克利普斯研究所 | 胰岛素免疫球蛋白融合蛋白 |
US20240024339A1 (en) * | 2020-11-19 | 2024-01-25 | Nippon Kayaku Kabushiki Kaisha | Composition containing water-soluble drug causing vascular disorder, solution for use in preparation of administration solution containing water-soluble drug causing vascular disorder, kit, agent for suppressing vascular disorder, and solution containing nonionic surfactant |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US224042A (en) * | 1880-02-03 | Music-rest for piano-fortes | ||
US670001A (en) * | 1900-02-15 | 1901-03-19 | Stephen B Morss | Combined curb and gutter. |
US4816247A (en) | 1985-09-11 | 1989-03-28 | American Cyanamid Company | Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs |
IL88076A (en) * | 1987-10-28 | 1993-01-14 | Nippon Shinyaku Co Ltd | Fat emulsions as drug carriers |
KR920700655A (ko) | 1989-05-26 | 1992-08-10 | 찰스 엠. 브럭 | 주사가능한 클라리트로마이신 조성물 |
US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
KR19990044445A (ko) | 1995-09-13 | 1999-06-25 | 니뽄 신야쿠 가부시키가이샤 | Pge1 함유 동결건조 제제 및 그 제법 |
CA2259179C (en) * | 1996-07-03 | 2008-09-23 | University Of Pittsburgh | Emulsion formulations for hydrophilic active agents |
IL131318A (en) * | 1997-04-28 | 2004-08-31 | Encysive Pharmaceuticals Inc | Pharmaceutically acceptable salts of sulfonamides for treatment of endothelin-mediated disorders |
US6723338B1 (en) | 1999-04-01 | 2004-04-20 | Inex Pharmaceuticals Corporation | Compositions and methods for treating lymphoma |
US6383471B1 (en) | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
US6720001B2 (en) * | 1999-10-18 | 2004-04-13 | Lipocine, Inc. | Emulsion compositions for polyfunctional active ingredients |
GB9925127D0 (en) | 1999-10-22 | 1999-12-22 | Pharmacia & Upjohn Spa | Oral formulations for anti-tumor compounds |
US6136846A (en) * | 1999-10-25 | 2000-10-24 | Supergen, Inc. | Formulation for paclitaxel |
JP2003277281A (ja) * | 2002-03-20 | 2003-10-02 | Kumamoto Technology & Industry Foundation | 静脈炎の予防及び治療のための医薬 |
US6890558B2 (en) | 2002-05-31 | 2005-05-10 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
JP4426749B2 (ja) * | 2002-07-11 | 2010-03-03 | 株式会社産学連携機構九州 | O/w型エマルション製剤 |
US20050049209A1 (en) * | 2003-08-06 | 2005-03-03 | Chen Andrew Xian | Pharmaceutical compositions for delivering macrolides |
EP1778217A4 (en) * | 2004-07-28 | 2008-10-08 | Sd Pharmaceuticals Inc | STABLE INJECTABLE COMPOSITION OF ALPHA-TOCOPHERYLSUCCINATE; ANALOGUE AND SALTS FROM IT " |
CN1634058A (zh) * | 2004-10-20 | 2005-07-06 | 李晓祥 | 长春瑞滨乳剂及其制备方法 |
-
2004
- 2004-07-12 US US10/889,226 patent/US7871632B2/en not_active Expired - Fee Related
-
2005
- 2005-07-12 JP JP2007521547A patent/JP4643641B2/ja not_active Expired - Fee Related
- 2005-07-12 EA EA200700312A patent/EA012522B1/ru not_active IP Right Cessation
- 2005-07-12 BR BRPI0513178-2A patent/BRPI0513178A/pt not_active IP Right Cessation
- 2005-07-12 KR KR1020077003386A patent/KR20070032816A/ko not_active Application Discontinuation
- 2005-07-12 AU AU2005271873A patent/AU2005271873A1/en not_active Abandoned
- 2005-07-12 CN CN2005800005998A patent/CN1859898B/zh not_active Expired - Fee Related
- 2005-07-12 RS RSP-2007/0029A patent/RS20070029A/sr unknown
- 2005-07-12 MX MX2007000416A patent/MX2007000416A/es unknown
- 2005-07-12 EP EP05772989A patent/EP1773294A4/en not_active Withdrawn
- 2005-07-12 CA CA2578574A patent/CA2578574C/en not_active Expired - Fee Related
- 2005-07-12 WO PCT/US2005/024594 patent/WO2006017246A2/en active Application Filing
- 2005-07-12 TW TW094123650A patent/TW200607525A/zh unknown
-
2006
- 2006-12-26 IL IL180350A patent/IL180350A0/en unknown
-
2007
- 2007-02-06 MA MA29665A patent/MA29662B1/fr unknown
- 2007-02-08 ZA ZA200701167A patent/ZA200701167B/xx unknown
- 2007-02-09 NO NO20070785A patent/NO20070785L/no not_active Application Discontinuation
- 2007-02-12 EC EC2007007238A patent/ECSP077238A/es unknown
- 2007-05-08 HK HK07104920.0A patent/HK1100062A1/xx not_active IP Right Cessation
-
2010
- 2010-12-10 US US12/965,676 patent/US8026250B2/en not_active Expired - Fee Related
-
2011
- 2011-08-17 US US13/212,140 patent/US8222268B2/en not_active Expired - Fee Related
-
2012
- 2012-06-21 US US13/530,039 patent/US20130029918A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
TW200607525A (en) | 2006-03-01 |
NO20070785L (no) | 2007-04-02 |
US8026250B2 (en) | 2011-09-27 |
EP1773294A4 (en) | 2012-11-21 |
WO2006017246A3 (en) | 2006-03-30 |
US20120046310A1 (en) | 2012-02-23 |
CA2578574C (en) | 2013-09-10 |
AU2005271873A1 (en) | 2006-02-16 |
CA2578574A1 (en) | 2006-02-16 |
US20060008480A1 (en) | 2006-01-12 |
EP1773294A2 (en) | 2007-04-18 |
ZA200701167B (en) | 2010-08-25 |
US20110082168A1 (en) | 2011-04-07 |
US20130029918A1 (en) | 2013-01-31 |
WO2006017246A2 (en) | 2006-02-16 |
CN1859898B (zh) | 2011-06-08 |
MX2007000416A (es) | 2007-03-28 |
JP4643641B2 (ja) | 2011-03-02 |
US8222268B2 (en) | 2012-07-17 |
RS20070029A (en) | 2008-11-28 |
EA012522B1 (ru) | 2009-10-30 |
HK1100062A1 (en) | 2007-09-07 |
KR20070032816A (ko) | 2007-03-22 |
EA200700312A1 (ru) | 2007-08-31 |
JP2008505972A (ja) | 2008-02-28 |
US7871632B2 (en) | 2011-01-18 |
IL180350A0 (en) | 2007-06-03 |
BRPI0513178A (pt) | 2008-04-29 |
MA29662B1 (fr) | 2008-08-01 |
CN1859898A (zh) | 2006-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP077238A (es) | Composiciones para entrega de drogas altamente solubles en agua | |
SG153800A1 (en) | Pharmaceutical compositions | |
PH12014500053A1 (en) | Proteasome inhibitors | |
BRPI0518228A (pt) | inibidores de cinesina mitótica e métodos de uso destes | |
BR112012011332A2 (pt) | agentes direcionados para gadd45beta | |
CR8642A (es) | Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos | |
CL2007000161A1 (es) | Compuestos derivados de 2,4-dioxoimidazolidina sustituida, inhibidores de proteinas cinasas; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer. | |
IS8398A (is) | Lyfjasamsetningar til að meðhöndla æxli | |
HK1085643A1 (en) | Uses and compositions for administration of capsaicin | |
SV2009003335A (es) | Formulaciones para el cancer | |
HK1112427A1 (en) | Drug delivery compositions and related methods | |
DK3072507T3 (da) | Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi | |
HK1244819A1 (zh) | Foxm1肽和包含foxm1肽的藥劑 | |
HK1142608A1 (en) | 5-pyridinone substituted indazoles and pharmaceutical compositions thereof 5- | |
EP1768685A4 (en) | COSMETIC COMPOSITIONS COMPRISING RHODIOLA ROSEA AND METHODS THEREOF | |
WO2008054808A3 (en) | Elvucitabine pharmaceutical compositions | |
CL2007003038A1 (es) | Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos. | |
HK1105886A1 (en) | Pharmaceutical compositions comprising l-733060 for use in the treatment of cancer tumours l-733060 | |
CL2008002082A1 (es) | Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades. | |
CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης | |
IL194775A (en) | Medicinal products containing anti-secretory protein for use in the treatment of dysfunction of floating fat rafts and / or kowala and / or its prevention | |
MX2009012370A (es) | Formulacion de antraciclina de baja viscosidad. | |
HK1111599A1 (en) | Pharmaceutical compositions for the treatment of cellulite | |
ATE469652T1 (de) | Depsipeptide zur verhinderung vertikaler endoparasiten-infektionen | |
MY146803A (en) | Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors |